Company Filing History:
Years Active: 2014-2015
Title: The Innovations of Barbara Perilli-Palmer: Pioneering Antibody Purification
Introduction
Barbara Perilli-Palmer, an accomplished inventor based in Bolton, MA, has made significant contributions to the field of biotechnology with her innovative work in antibody purification. With two patents to her name, she is recognized for her expertise in developing methods that enhance the quality of pharmaceutical compositions.
Latest Patents
Perilli-Palmer's latest patents focus on the "Isolation and purification of antibodies using protein A affinity chromatography." These patents disclose methods designed for the effective isolation and purification of antibodies, utilizing an affinity chromatographic step to yield compositions that meet the stringent requirements for pharmaceutical applications. The methods combine pH viral reduction/inactivation, ultrafiltration/diafiltration, and a range of chromatography techniques, including protein A affinity and ion exchange chromatography. Additionally, her inventions include formulations of pharmaceutical compositions that comprise one or more antibodies purified by these methods.
Career Highlights
Barbara Perilli-Palmer is currently affiliated with AbbVie Inc., a global biopharmaceutical leader known for its advanced research and development in healthcare. Her work within the company showcases her commitment to improving therapeutic solutions and underscores her pivotal role in advancing antibody purification techniques.
Collaborations
Throughout her career, Perilli-Palmer has worked alongside esteemed colleagues such as Robert K. Hickman and Qing Huang. Their collaborations have fostered an environment of innovation, contributing to significant advancements in the field and furthering the impact of their collective research.
Conclusion
Barbara Perilli-Palmer exemplifies the spirit of innovation in biotechnology through her inventive methods for antibody purification. Her patents not only enhance pharmaceutical applications but also highlight her dedication to advancing scientific knowledge, making her a key player in the biopharmaceutical industry. With ongoing contributions to the field, the future looks promising for her continued influence in the realm of antibody research.